Experimental study on liver regeneration after simultaneous partial hepatectomy and pancreatectomy

Hepatology Research

Volumn 17, Issue 3, 2000, Pages 223-236

  Furuta, Kazunori ^a   Kakita, Akira ^a   Takahashi, Tsuyoshi ^a   Tomiya, Tomoaki ^b   Fujiwara, Kenji ^c  

^a KITASATO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Hepatectomy; Liver regeneration; Pancreatectomy; TGF

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CYCLINE; GLUCAGON; INSULIN; KETONE BODY; SUGAR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCRINE FUNCTION; EVISCERATION; GLUCAGON BLOOD LEVEL; HORMONE RELEASE; INSULIN BLOOD LEVEL; LIVER REGENERATION; LIVER WEIGHT; MALE; NONHUMAN; PANCREAS RESECTION; PARTIAL HEPATECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RAT;

EID: 0034118838     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(99)00078-9     Document Type: Article

References (33)

1. Kakita A., Manabe Y., Nakajima Y. et al. Hepato-pancreatic relationship and evaluation of resectability in simultaneous extended resection of liver and pancreas. Med. Philos. 9:1990;573-575.
2. Nimura Y., Hayakawa N., Kamiya J. et al. Hepatopancreatoduodenectomy for advanced carcinoma of the biliary tract. Hepato-Gastroenterology. 38:1991;170-175.
3. Nakase I., Kawarada Y., Kawamura K. et al. Studies on simulataneous major resection of the liver and the pancreas with special reference to carbohydrate metabolism. Arch. Jpn. Chir. 52:1988;152-164.
4. Price J.B., Takeshige K., Max M.H. et al. Glucagon as the portal factor modifying hepatic regeneration. Surgery. 72:1972;74-82.
5. Bucher N.L., Swaffield M.N. Regulation of hepatic regeneration in rats by synergistic action of insulin and glucagon. Proc. Natl. Acad. Sci. USA. 72:1975;1157-1160.
6. Starzl T.E., Porter K.A., Kashiwagi N. et al. Portal hepatotrophic factors, diabetes mellitus and acute liver atrophy, hypertrophy and regeneration. Surg. Gynecol. Obstet. 141:1975;843-858.
7. Starzl T.E., Watanabe K., Porter K.A. et al. Effects of insulin, glucagon and insulin/glucagon infusion on liver morphology and cell division after complete portocaval shunt in dogs. Lancet. 2:1976;821-825.
8. Kurauchi N. The limitis of resection in hepatopancreatectomies in rats. Hokkaido Med. J. Sci. 71:1996;699-710.
9. Higgins G.M., Anderson R.M. Experimental pathology of liver I. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 12:1931;186-202.
10. Richard C., Fizgerald P.J., Carol B. et al. Segmental division of the rat panceras for experimental procedures. Lab. Invest. 13:1964;1303-1321.
11. Fishback FC. A morphologic study of regeneration of the liver after partial removal. Arch Pathol 1929;1:955-977.
12. Derynck R. The physiology of transforming growth factor-a. Adv. Cancer Res. 58:1992;27-52.
13. Fausto N. Hepatic regeneration. Zakim D., Boyer T.D. Hepayology, A Textbook of Liver Disease. 1:1990;49-65 Saunders, Philadelphia.
14. Tomiya T., Fujiwara K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked imumunosorbent assay. Hepatology. 18:1993;304-308.
15. Bucher N.L., Glions A.D. The effect of age on generation of rat liver. Cancer Res. 46:1950;324.
16. Suzaki M. Studies on simulaneous major resection of the liver and the pancreas, with special reference to resectability, liver function and regeneration. Arch. Jpn. Chir. 56:1987;46-61.
17. Kurashita K. Serial change of pancreatic hormone and its influence on liver regeneration after simulataneous resection of the liver and pancreas. Ryukyu Med. J. 13:1993;267-277.
18. Child C.G. III, Barr D., Holswade G.R. et al. Liver regeneration following portacaval transposition in dogs. Ann. Surg. 138:1953;600-608.
19. Galand P., Degraef C. Cyclin/PCNA immunostaining as an altenative to tritiated thymidine pulse labelling for marking S-phase cell in paraffin sections from animal and human tissues. Cell Tissue Kinet. 22:1989;383-392.
20. Garcia R.L., Coltera M.D., Gown A.M. Analysis of proliferative grade using anti-PCNA/Cyclin monoclonal antibodies in fixed, embedded tissues. Comparison with flow cytometric analisis. Am. J. Pathol. 134:1989;733-739.
21. Fukuda T., Aoki T., Yamatsu K. et al. Immunohistolochemical study of BrdU and PCNA as useful markers of cell proliferation in regenerative liver and D-galactosamine-treated liver in rats. J. Toxicol. Pathol. 8:1995;73-80.
22. Nakamura T., Nawa K., Ichikawa A. Partial purification and characterization of hepatocyte growth factor from serum of hepatomized rats. Biochem. Biophys. Res. Commun. 122:1984;1450-1459.
23. Tani M., Tomiya T., Yamada S. et al. Regulating factors of liver regeneration after hepatectomy. Cancer Chemother. Pharmacol. 33:1994;29-32.
24. Miyazaki S., Takasaki K., Yamamoto M. Change in human hepatocyte growth factor hHGF and regeneration of remnant liver following hepatectomy. J. Tokyo Women's Med. Coll. 163:1993;995-1000.
25. Tomiya T., Fujiwara K. The meaning and movement of transforming growth factor-α in liver regeneration. Acta Hepatol. Jpn. 36:1995;121-122.
26. George K.M. Control mechanisms of liver regeneration. J. Gastroenterol. 29:1994;23-29.
27. Mead J.E., Fausto N. Transforming growth factor-α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA. 86:1989;1558-1562.
28. Bucher N.L. Aspects of Hormonal Influence on Liver Growth Glucagon in Gastroenterology and Hepatology. 1982;141 MTA Press, Lancaster.
29. Itatsu T., Kishimoto T., Shintani T. et al. The release and metabolism of pancreatic hormones after major hepatectomy in the dog. Endocrinol. Jpn. 26:1979;319-324.
30. Tsubouchi H., Miyazaki H., Gohda E. et al. Degradation of (125I) iodoglucagon by normal rat plasma in radioimmunoassay mixture containing aprotinin and its prevention by p-chlromercuriphenyl sulfonate and leupeptin. Endocrinology. 119:1986;1137-1145.
31. Tsubouchi H., Gohda E., Miyazaki H. et al. Glucagon degeneration in fraction of big plasma glucagon in rats treated with carbon tetrachloride. Endocrinol. Jpn. 30:1983;577-583.
32. Woolf G.M., Redeker A.G. Treatment of fulminant hepatic failure with insulin and glucagon: a randomized controlled trial. Dig. Dis. Sci. 36:1991;92-96.
33. Harrison P.M., Hughes R.D., Forbes A. et al. Failure of insulin and glucagon infusion to stimulate liver regeneration in fulminant hepatic failure. J. Hepatol. 10:1990;332-336.